0002007317-24-000038.txt : 20240131 0002007317-24-000038.hdr.sgml : 20240131 20240131165727 ACCESSION NUMBER: 0002007317-24-000038 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARROWHEAD PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000879407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460408024 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38042 FILM NUMBER: 24583743 BUSINESS ADDRESS: STREET 1: 177 E COLORADO BLVD STREET 2: SUITE 700 CITY: PASADENA STATE: CA ZIP: 91105 BUSINESS PHONE: 626-696-4702 MAIL ADDRESS: STREET 1: 177 E COLORADO BLVD STREET 2: SUITE 700 CITY: PASADENA STATE: CA ZIP: 91105 FORMER COMPANY: FORMER CONFORMED NAME: ARROWHEAD RESEARCH CORP DATE OF NAME CHANGE: 20040112 FORMER COMPANY: FORMER CONFORMED NAME: INTERACTIVE GROUP INC DATE OF NAME CHANGE: 20020509 FORMER COMPANY: FORMER CONFORMED NAME: INTERACTIVE INC DATE OF NAME CHANGE: 19940224 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Anzalone Christopher Richard CENTRAL INDEX KEY: 0001423029 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: ARROWHEAD RESEARCH CORPORATION STREET 2: 201 SOUTH LAKE AVENUE, SUITE 703 CITY: PASADENA STATE: CA ZIP: 91101 144 1 primary_doc.xml 144 0001423029 XXXXXXXX LIVE 0000879407 ARROWHEAD PHARMACEUTICALS, INC. 001-38042 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702 Anzalone Christopher Richard Officer Common Merrill Lynch

75 Rockefeller Plz Flr 2 New York NY 10019

57499 1859992.22 107432210 01/31/2024 NASDAQ Common 02/06/2014 Compensation Christopher Anzalone N 57499 01/31/2024 Compensation N Christopher Anzalone

177 E Colorado Blvd Ste. 700 Pasadena CA 91105

Common 12/21/2023 12000 342408.03 Christopher Anzalone

177 E Colorado Blvd Ste. 700 Pasadena CA 91105

Common 01/02/2024 9952 308622.17 01/31/2024 03/22/2023 Christopher Anzalone